These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 37465289)

  • 1. Glucose metabolic reprogramming in autoimmune diseases.
    Jeong H; Lee B; Han SJ; Sohn DH
    Anim Cells Syst (Seoul); 2023; 27(1):149-158. PubMed ID: 37465289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunometabolism: an overview and therapeutic prospects in autoimmune diseases.
    Stathopoulou C; Nikoleri D; Bertsias G
    Immunotherapy; 2019 Jun; 11(9):813-829. PubMed ID: 31120393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes.
    Frazzei G; van Vollenhoven RF; de Jong BA; Siegelaar SE; van Schaardenburg D
    Front Immunol; 2022; 13():899372. PubMed ID: 35844538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycolysis in Innate Immune Cells Contributes to Autoimmunity.
    Xu Y; Chen Y; Zhang X; Ma J; Liu Y; Cui L; Wang F
    Front Immunol; 2022; 13():920029. PubMed ID: 35844594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
    Tzeng HT; Chyuan IT
    J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction.
    Gharagozloo M; Majewski S; Foldvari M
    Nanomedicine; 2015 May; 11(4):1003-18. PubMed ID: 25596076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Iwata S; Tanaka Y
    Expert Rev Clin Immunol; 2021 Oct; 17(10):1121-1130. PubMed ID: 34351835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren's Syndrome.
    Ortíz-Fernández L; Martín J; Alarcón-Riquelme ME
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):392-411. PubMed ID: 35749015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose transporter 1 in rheumatoid arthritis and autoimmunity.
    Zezina E; Sercan-Alp O; Herrmann M; Biesemann N
    Wiley Interdiscip Rev Syst Biol Med; 2020 Jul; 12(4):e1483. PubMed ID: 32084302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Targets for Treatment of Autoimmune Diseases.
    Piranavan P; Bhamra M; Perl A
    Immunometabolism; 2020; 2(2):. PubMed ID: 32341806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis.
    Szymczak F; Colli ML; Mamula MJ; Evans-Molina C; Eizirik DL
    Sci Adv; 2021 Jan; 7(2):. PubMed ID: 33523973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis.
    Yoon N; Jang AK; Seo Y; Jung BH
    Metabolites; 2021 Nov; 11(12):. PubMed ID: 34940570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4
    Badam TV; Hellberg S; Mehta RB; Lechner-Scott J; Lea RA; Tost J; Mariette X; Svensson-Arvelund J; Nestor CE; Benson M; Berg G; Jenmalm MC; Gustafsson M; Ernerudh J
    Epigenetics; 2022 Sep; 17(9):1040-1055. PubMed ID: 34605719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
    Bellinger DL; Lorton D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases. Perspectives and therapeutic aspects.
    Harifi G; Sibilia J
    Saudi Med J; 2016 Apr; 37(4):354-60. PubMed ID: 27052277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis.
    Qiu J; Wu B; Goodman SB; Berry GJ; Goronzy JJ; Weyand CM
    Front Immunol; 2021; 12():652771. PubMed ID: 33868292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy.
    Adams Waldorf KM; Nelson JL
    Immunol Invest; 2008; 37(5):631-44. PubMed ID: 18716941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of CD38 protein as a target for autoimmune diseases.
    Ye X; Zhao Y; Ma W; Ares I; Martínez M; Lopez-Torres B; Martínez-Larrañaga MR; Wang X; Anadón A; Martínez MA
    Autoimmun Rev; 2023 Apr; 22(4):103289. PubMed ID: 36750136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis and systemic lupus erythematosus: Pathophysiological mechanisms related to innate immune system.
    Pabón-Porras MA; Molina-Ríos S; Flórez-Suárez JB; Coral-Alvarado PX; Méndez-Patarroyo P; Quintana-López G
    SAGE Open Med; 2019; 7():2050312119876146. PubMed ID: 35154753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.